Novogene Establishes First Australian Genomics Laboratory at Cabrini Health to Advance Precision Oncology
Novogene, a global multi-omics leader, is establishing its first Australian genomics laboratory at Cabrini Health in Melbourne. This joint laboratory, expected to open in 2027, will be strategically located within the clinical and cancer research precinct at Cabrini Malvern, making it Australia's first genomics laboratory co-located within a private hospital. The initiative aims to bring advanced genomic capabilities closer to Australian patients and researchers, significantly reducing the waiting time for genomic test results that inform cancer treatment decisions. This integration of genomic testing within the clinical environment is expected to enable faster turnaround from biopsy to genomic results, supporting more timely clinical decision-making and treatment initiation for cancer patients. The precision oncology program supporting this new laboratory has secured substantial investment, including a $10 million grant from the PMF Foundation and a $5 million Australian Government grant. 
